About this blog

CRIT is no longer adding posts or updating the CRITical Thinking blog.

CRITical Thinking is a blog written by staff, directors, and friends of the Collaboration for Research Integrity and Transparency (CRIT), a joint program of Yale Law School, Yale School of Public Health, and Yale School of Medicine. CRIT's mission is to promote health by improving the integrity and transparency of biomedical and clinical research.

This blog is published by and reflects the personal views of the individual authors, in their individual capacities. It does not purport to represent Yale University's institutional views, if any. No representation is made about the accuracy of the information, which solely constitutes the authors’ personal views on issues discussed. The information contained in this blog is provided only as general information and personal opinions, and blog topics may be updated after being initially posted.


CRITical Thinking Blog

Appeals Court Rules in Favor of Transparency in Avandia Marketing Suit

May 15, 2019

The United States Court of Appeals for the Third Circuit adopted issued a decision adopting the reasoning advocated in an amicus brief submitted by CRIT.

Read more

Prospective registration among trials published in specialty society journals: We can do more to promote transparency and research integrity

August 23, 2018
By Joshua D. Wallach, Anand D. Gopal, Joseph S. Ross

In order to improve the integrity and transparency of medical research, there has been a growing movement toward prospective clinical trial registration.

Read more

Transparency By Sleight of Hand?

January 3, 2018
By Matthew Herder

Members of the modern pharmaceutical industry were once known as “ethical manufacturers” because they eschewed the secrecy and quackery of their “proprietary medicine” predecessors.

Read more

New Study Documents Harm Caused by Evidence Distortion in Medical Research

December 18, 2017
By Margaret McCarthy

Four health integrity organizations have come together to call on governments to ensure that patients, doctors, and scientists can access the full results of all clinical trials.

Read more